Nuveen’s Exagen XGN Stock Holding History

Nuveen’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,388	Closed	-$142K	–	3504
2022 Q1	$142K	Hold	17,388	–	–	﹤0.01%	3227
2021 Q4	$169K	Sell	17,388 -12,050	-41%	-$141K	﹤0.01%	3255
2021 Q3	$425K	Sell	29,438 -1,542	-5%	-$20.5K	﹤0.01%	3197
2021 Q2	$465K	Buy	30,980 +19,592	+172%	+$300K	﹤0.01%	3171
2021 Q1	$199K	Hold	11,388	–	–	﹤0.01%	3237
2020 Q4	$150K	Hold	11,388	–	–	﹤0.01%	3222
2020 Q3	$123K	Hold	11,388	–	–	﹤0.01%	3203
2020 Q2	$141K	Buy	+11,388	New	+$154K	﹤0.01%	3141

Other funds holding XGN

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Nuveen's XGN Position: Q2 2022 in Review

Nuveen sold out of Exagen (XGN) in Q2 2022, closing a stake of 17,388 shares — an estimated $142K sold.

Nuveen first reported a position in XGN in Q2 2020 and held it in 8 quarters. The position peaked at $465K in Q2 2021. 47 funds tracked by Wall St. Rank hold XGN as of Q2 2022.

Nuveen reported no remaining Exagen position as of Q2 2022 after selling out during the quarter.
Nuveen sold 17,388 Exagen shares in Q2 2022, an estimated $142K.
Nuveen first reported a position in Exagen in Q2 2020 and held it in 8 quarters.
Nuveen's Exagen position peaked at $465K in Q2 2021.
47 funds tracked by Wall St. Rank held Exagen as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.